GEN Exclusives

More »

GEN News Highlights

More »
Jul 27, 2012

BMS Awards Grants Focused on Combatting HBV and HCV in China and India

  • As part of its Delivering Hope™ program, Bristol-Myers Squibb has awarded four new grants totaling $1.69 million to improve prevention, care, and support of HBV and HCV in China and India. China and India account for almost 50% of all hepatitis B (HBV) and hepatitis C (HCV) infections worldwide, having an estimated 123 million people chronically infected with HBV and 59 million people chronically infected with HCV.

    The recipients of the new grants are long-term partners of Delivering Hope™. Organizations and projects receiving support are China Foundation for Hepatitis Prevention and Control, HOPE Initiative, Liver Foundation West Bengal, and a coalition that includes the United Way of Mumbai, the National Liver Foundation, and AmeriCares India.

    China Foundation for Hepatitis Prevention and Control will receive $401,687 over three years to create a HBV and HCV patient empowerment model to enhance patients’ ability to manage their disease. HOPE Initiative will receive $355,694 over three years to create a HCV patient support network and conduct studies to explore the effectiveness of blood donation and transfusion regulations. Liver Foundation West Bengal will receive $539,035 to develop comprehensive interventions for patients who have HBV or HCV and comorbid non-communicable diseases such as type 2 diabetes, hypertension, cardiovascular disease, and fatty liver disease. United Way of Mumbai, the National Liver Foundation and AmeriCares India will receive $389,464 over two years for efforts targeted at the prevention and care of HBV and HCV in pregnant women and women of childbearing age.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »